Company Description
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.
The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services.
Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
| Country | United States |
| Founded | 1996 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14,300 |
| CEO | Anshul Thakral |
Contact Details
Address: 8 Moore Drive Durham, North Carolina 27709 United States | |
| Phone | 877 495 0816 |
| Website | fortrea.com |
Stock Details
| Ticker Symbol | FTRE |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1965040 |
| CUSIP Number | 34965K107 |
| ISIN Number | US34965K1079 |
| Employer ID | 92-2796441 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Anshul Thakral | Chief Executive Officer and Director |
| Jill McConnell | Chief Financial Officer |
| Mark A. Morais | Chief Operating Officer and President of Clinical Services |
| Drayton Virkler | President and Chief Commercial Officer |
| Robert Parks | Chief Accounting Officer |
| Alejandro Martinez Galindo | Chief Information Officer |
| Dave Cooper | Chief Administrative Officer |
| Tracy H. Krumme | Senior Vice President of Investor Relations |
| Agnieszka M. Gallagher J.D. | General Counsel |
| Hima B. Inguva | Head of Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 16, 2026 | 144 | Filing |
| Mar 16, 2026 | 144 | Filing |
| Mar 10, 2026 | 144 | Filing |
| Mar 10, 2026 | 144 | Filing |
| Mar 10, 2026 | 144 | Filing |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Feb 10, 2026 | 144 | Filing |
| Feb 10, 2026 | 144 | Filing |